RNTXRein Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Rein Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RNTXEsta | $61M#9 | — | 1.1x#7 | — | — | 20.7%#5 | — | -90.4%#9 | — | — | -38.7%#8 | — |
| PLRX | $67M#2 | — | 0.5x#1 | — | — | -29.0%#10 | — | 101.6%#1 | — | — | -28.5%#7 | — |
| XBIT | $66M#3 | — | 0.5x#2 | — | -100.0%#7 | -18.2%#9 | — | -35.5%#4 | — | — | — | — |
| SPRO | $66M#4 | 8.0x#3 | 1.5x#8 | 5.2x#4 | 3292.5%#1 | 112.5%#1 | 50.2%#1 | 19.4%#2 | — | — | — | — |
| BOLD | $64M#5 | — | 1.0x#6 | — | — | 11.0%#6 | — | -88.2%#8 | — | — | 148.7%#1 | — |
| EVFM | $63M#6 | — | — | 3.1x#3 | 4.2%#5 | 104.4%#2 | 16.7%#2 | — | — | — | — | — |
| TLPH | $62M#7 | — | 4.3x#10 | 2206.0x#9 | — | -9.9%#8 | -48157.1%#9 | -99.2%#10 | — | — | 21.4%#3 | — |
| SKYE | $61M#8 | — | — | — | — | -110.5%#15 | — | — | — | — | -94.4%#12 | — |
| HRTX | $60M#10 | — | 8.7x#12 | 0.4x#1 | 7.4%#4 | -42.9%#11 | -1.6%#3 | -289.5%#12 | — | — | -74.2%#11 | — |
| IBIO | $77M#1 | — | 0.9x#5 | 765.3x#7 | -75.0%#6 | -78.7%#14 | -35141.0%#8 | -38.3%#5 | — | — | 37.3%#2 | — |
| DWTX | $59M#11 | 0.9x#2 | 0.9x#4 | — | — | -177.4%#16 | — | -50.1%#7 | — | — | -65.2%#10 | — |
| IBO | $58M#12 | 0.6x#1 | 5.3x#11 | 1797.2x#8 | — | 52.1%#3 | -13381.3%#6 | -110.0%#11 | -18.9%#1 | — | -22.7%#6 | — |
| SER | $57M#13 | — | — | 436.7x#6 | 132.1%#3 | -72.2%#13 | -18478.5%#7 | — | — | 5#1 | -56.2%#9 | — |
| NMAD | $56M#14 | — | 2.4x#9 | 281.0x#5 | — | -69.5%#12 | -2553.8%#5 | -25.4%#3 | — | — | — | — |
| PDSB | $55M#15 | — | — | — | — | 8.3%#7 | — | — | -541.6%#2 | — | -16.5%#5 | — |
| XLO | $52M#16 | — | 0.7x#3 | 1.2x#2 | 589.9%#2 | 39.8%#4 | -95.9%#4 | -48.5%#6 | — | — | -15.4%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice